Cancer (neoplasms): Lung (non-small cell) Cancer Lung cancer
Conditions
Interventions
1. Conventional medical follow-up:
At the specialist cancer hospital, patients were seen within one month and, if stable, discharged back to their referring cancer unit. At the cancer units, follow-up
Sponsors
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with lung cancer having completed initial treatment 2. Not requiring immediate medical intervention or close medical supervision 3. Considered to have a good performance status (World Health Organization [WHO] performance status 0 - 2) 4. Had an expected prognosis of at least 3 months 5. Were not participating in other clinical trials requiring intensive medical investigation or follow-up 6. Understood and read English for informed consent and data collection purposes
Exclusion criteria
Exclusion criteria: Not provided at time of registration
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Secondary
| Measure | Time frame |
|---|---|
| Not provided at time of registration | — |
Countries
United Kingdom
Outcome results
None listed